Retinoblastoma and Secondary Cancer

Janet L. Kwiatkowski, MD
Last Modified: November 1, 2001

Question
Dear OncoLink "Ask the Experts,"
I had bilateral (hereditary) retinoblastoma when I was a child. What is my risk of developing other cancers later in life?


Answer
Janet L. Kwiatkowski, MD, OncoLink's Pediatric Oncology Section Editor, responds:

Dear OncoLink Reader:
Thank you for your question.

Two forms of retinoblastoma exist, a hereditary form and a non-hereditary form. Patients with retinoblastoma involving both eyes or patients with tumor in one eye and a family history of retinoblastoma are considered to have the hereditary form.

Patients with the hereditary form of retinoblastoma have an increased risk of developing other cancers later in life. This is attributable primarily to a germline (passed to all of the bodyís cells) mutation in the retinoblastoma tumor suppresser gene, RB1. Mutations in this gene have also been linked to other tumors in addition to retinoblastoma. The most common secondary tumors that develop in patients with hereditary retinoblastoma are bone and soft tissue sarcomas. Radiation therapy, one of the treatments frequently used in the treatment of retinoblastoma, further increases the risk of developing a second malignancy in patients with hereditary retinoblastoma. Therefore, it is important for all patients with a history of hereditary retinoblastoma to be followed closely by their physicians.

If you would like more information about retinoblastoma you can refer to the OncoLink Retinoblastoma section.

Blogs

Survivorship Benefits of Proton Therapy
by OncoLink Editorial Team
June 17, 2015

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015

Related News

Risk-Based Chemo Is Effective for Retinoblastoma

Mar 6, 2013

Using a classification strategy, all patients event-free at a median 71 months of follow-up


Cancer Risk Up in Bilateral Retinoblastoma Survivors

Feb 24, 2012

Survivors with family history have elevated risk of secondary cancers, especially melanoma


Team Approach Improves Retinoblastoma Management

Nov 17, 2011

Using multidisciplinary care, genetic analysis done in 63 percent of retinoblastoma probands


From the National Cancer Institute